Place of levocetirizine in the treatment of allergic rhinitis



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Levocetirizine is an effective Hj-blocker in complex treatment of various allergic patients. Allergic rhinitis is often part of a systemic allergic inflammation associated with other allergic diseases, therefore systemic antihistamines are the drugs of choice in it’s treatment.

Full Text

Restricted Access

About the authors

E F Glushkova

NRC Institute of Immunology FMBA ofRussia

Email: glushkovaef@gmail.com

N V Shartanova

NRC Institute of Immunology FMBA ofRussia

References

  1. Аллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М.: «ГЭО-ТАР-Медиа». 2009: 656
  2. Елисютина ОГ, Штырбул О.В. Левоцетиризин в клинической практике врача-аллерголога. Российский Аллергологический Журнал. 2016; (3): 49-58
  3. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J. Allergy Clin Immunol. 2001; 108: 147-334.
  4. Church M., Church D. Pharmacology of antihistamines. Indian J. Dermatol. 2013: 58: 219-224.
  5. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: «Фармарус принт». 1998: 252
  6. Гущин И.С. Разнообразие противоаллергического действия цетиризина. Российский Аллергологический Журнал. 2006; (4): 33-44
  7. Leurs R., Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy. 2002; 32: 489-498.
  8. Астафьева НГ, Гамова ИВ, Удовиченко ЕН, Перфило-ва И.А. Левоцетиризин: современные аспекты применения при аллергических заболеваниях с точки зрения доказательной медицины. Лечащий врач. 2010; (5): 62-75
  9. Holgate ST, Canonica GW, Simons FE, Taglialatela M., Tharp M., Timmerman H. et al. Consensus group on new-generation antihistamines (CONGA): present status and recommendations. Clinical & Experimental Allergy. 2003; 33: 1305-1324.
  10. Chen C. Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine. Curr Med Chem. 2008; 15: 2173-2191.
  11. Klimek L. Levocetirizine: from scientific evidence to a potent modern-day treatment oftoday’s allergic patients. Drugs Today (Barc.). 2009; 45: 213-225.
  12. Gillard M., Van Der Perren C., Moguilevsky N., Massingham R., Chatelain P. Binding characteristics of cetirizine and levocetirizine to human H1-histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol. 2002; 61: 391-399.
  13. Molimard M., Diquet B., Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol. 2004; 18: 399-411.
  14. Simons FER, Simons KJ. H1-Antihistamines: Current Status and Future Directions. World Allergy Organ J. 2008; 1: 145-155.
  15. Хаитов РМ, Ильина Н.И. Аллергология. Федеральные клинические рекомендации. М.: «Фармарус Принт Медиа». 2014: 124
  16. Лусс ЛВ, Сидорович О.И. Аллергический ринит и аллергический конъюнктивит: механизм взаимосвязи и тактика лечения. Астма и аллергия. 2015; (1): 31-34
  17. Bousquet J., Van Cauwenberge P., Bachert C., Canonica GW, Demoly P., Durham SR et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI). Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003; 58: 192-197.
  18. Deruaz C., Leimgruber A., Berney M., Pradervand E., Spertini F. Better protects than desloratadine in a nasal provocation with allergen. J. Allergy Clin Immunol. 2004; 113: 669-676.
  19. Bachert C., Bousquet J., Canonica GW, Durham SR, Klimek L., Mullol J. et al. XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J. Allergy Clin Immunol. 2004; 114: 838-844.
  20. Jorissen M., Bertrand B., Stiels B., Vandenbulcke K. Levocetirizine as treatment for symptoms of seasonal allergic rhinitis. B-ENT 2006; 2: 55-62.
  21. De Blic J., Wahn U., Billard E., Alt R., Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005; 16: 267-275.
  22. Simons FE. Safety of levocetirizine treatment in young atopic children: An 18-month study. Pediatr Allergy Immunol. 2007; 18: 535-542.
  23. Гущин И.С. Обратные агонисты H1-рецепторов как перспективные противоаллергические средства (обзор). Химико-фармацевтический журнал. 2010; (1): 3-8

Copyright © Pharmarus Print Media, 2018



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies